The incorporation of patients' perspectives into drug discovery and development has become critically important from the viewpoint of accounting for modern-day business dynamics. There is a trend among patients to narrate their disease experiences on social media. The insights gained by analyzing the data pertaining to such social-media posts could be leveraged to support patient-centered drug development. Manual analysis of these data is nearly impossible, but artificial intelligence enables automated and cost-effective processing, also referred as social media mining (SMM). This paper discusses the fundamental SMM methods along with several relevant drug-development use cases.
No takes yet. Share an insight, caveat, or question.
Koss et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: